Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma. Read more about Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma. Read more about Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
ACR appropriateness criteria® nasal cavity and paranasal sinus cancers. Read more about ACR appropriateness criteria® nasal cavity and paranasal sinus cancers.
Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma. Read more about Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas. Read more about ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma. Read more about Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma.
Implementation of a comprehensive competency-based transoral robotic surgery training curriculum with ex vivo dissection models. Read more about Implementation of a comprehensive competency-based transoral robotic surgery training curriculum with ex vivo dissection models.
ACR Appropriateness criteria® for nasopharyngeal carcinoma. Read more about ACR Appropriateness criteria® for nasopharyngeal carcinoma.
ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck. Read more about ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.
Regional variation in head and neck cancer mortality: Role of patient and hospital characteristics. Read more about Regional variation in head and neck cancer mortality: Role of patient and hospital characteristics.
